New Developments in Hodgkin's Lymphoma, An Issue of Hematology/Oncology Clinics of North America
Series: The Clinics: Internal Medicine;
- Publisher's listprice EUR 100.99
-
39 446 Ft (37 568 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 7 889 Ft off)
- Discounted price 31 557 Ft (30 054 Ft + 5% VAT)
- Discount is valid until: 30 June 2026
Subcribe now and take benefit of a favourable price.
Subscribe
39 446 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Health Sciences
- Date of Publication 27 March 2026
- ISBN 9780443472329
- Binding Hardback
- No. of pages pages
- Weight 450 g
- Language English 690
Categories
Long description:
In this issue of Hematology/Oncology Clinics, guest editors Drs. Alex F. Herrera and Alison J. Moskowitz bring their considerable expertise to the topic of New Developments in Hodgkin's Lymphoma. Top experts focus on how advances in our understanding of Hodgkin’s lymphoma biology, diagnostics, and novel therapies have revolutionized the management of Hodgkin’s lymphoma.
- Contains 13 relevant, practice-oriented topics including updates in our understanding of the biology of classic Hodgkin’s lymphoma; new standards in advanced stage Hodgkin’s lymphoma: selecting a novel regimen; adolescents and young adults with Hodgkin’s lymphoma; management of classic Hodgkin’s lymphoma in pregnancy; health disparities in classic Hodgkin’s lymphoma; and more
- Provides in-depth clinical reviews on new developments in Hodgkin's lymphoma, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Table of Contents:
Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime?
Early-Stage Hodgkin Lymphoma: Time for Novel Agents?
New Standards in Advanced-stage Hodgkin Lymphoma: Selecting a Novel Regimen
Classic Hodgkin Lymphoma in the Older Adult: What’s New?
Management of Classic Hodgkin Lymphoma in Pregnancy
New Developments in Hodgkin’s Lymphoma: Outcomes and Disparities in Classic Hodgkin Lymphoma
The Modern Role of Radiation Therapy in Classic Hodgkin Lymphoma
Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies
The Role of Stem Cell Transplantation in Hodgkin Lymphoma
Cellular and Novel Immunotherapies for Classic Hodgkin Lym
